Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Coeptis Therapeutics Holdings (COEPW) Shares Issued (2022 - 2025)

Coeptis Therapeutics Holdings has reported Shares Issued over the past 4 years, most recently at $250.0 for Q4 2025.

  • Quarterly results put Shares Issued at $250.0 for Q4 2025, up 100.05% from a year ago — trailing twelve months through Dec 2025 was $5.0 million (changed N/A YoY), and the annual figure for FY2025 was $900.0, changed.
  • Shares Issued for Q4 2025 was $250.0 at Coeptis Therapeutics Holdings, down from $5.0 million in the prior quarter.
  • Over the last five years, Shares Issued for COEPW hit a ceiling of $5.0 million in Q3 2025 and a floor of -$500000.0 in Q4 2024.
  • Median Shares Issued over the past 4 years was $500000.0 (2024), compared with a mean of $870203.3.
  • Biggest five-year swings in Shares Issued: soared 119999900.0% in 2023 and later tumbled 141.67% in 2024.
  • Coeptis Therapeutics Holdings' Shares Issued stood at $1.0 in 2022, then soared by 119999900.0% to $1.2 million in 2023, then tumbled by 141.67% to -$500000.0 in 2024, then skyrocketed by 100.05% to $250.0 in 2025.
  • The last three reported values for Shares Issued were $250.0 (Q4 2025), $5.0 million (Q3 2025), and $500.0 (Q2 2025) per Business Quant data.